Jeremy Sugarman, MD, MPH, MA

Core Faculty; Deputy Director for Medicine; Harvey M. Meyerhoff Professor of Bioethics and Medicine


1809 Ashland Ave.
Room 203
Baltimore, MD 21205
  • Deputy Director for Medicine
    Johns Hopkins Berman Institute of Bioethics
  • Harvey M. Meyerhoff Professor of Bioethics and Medicine
    Johns Hopkins Berman Institute of Bioethics
    Johns Hopkins School of Medicine
  • Professor of Health Policy and Management
    Johns Hopkins Bloomberg of Public Health

Jeremy Sugarman, MD, MPH, MA is the Harvey M. Meyerhoff Professor of Bioethics and Medicine, professor of medicine, professor of Health Policy and Management, and deputy director for medicine of the Berman Institute of Bioethics at the Johns Hopkins University. He is an internationally recognized leader in bioethics with particular expertise in applying empirical methods and evidence-based standards for evaluating and analyzing bioethical issues. His contributions to bioethics and policy include his work on the ethics of informed consent, umbilical cord blood banking, stem cell research, international HIV prevention research, global health and research oversight.

Read More

Dr. Sugarman is the author of over 350 articles, reviews and book chapters.  He has also edited or co-edited four books (Beyond Consent: Seeking Justice in Research; Ethics of Research with Human Subjects: Selected Policies and Resources; Ethics in Primary Care; and Methods in Medical Ethics).  Dr. Sugarman is on the editorial boards of several academic journals.

Dr. Sugarman consults and speaks internationally on a range of issues related to bioethics. He was senior policy and research analyst for the White House Advisory Committee on Human Radiation Experiments, consultant to the National Bioethics Advisory Commission, and Senior Advisor to the Presidential Commission for the Study of Bioethical Issues. He also served on the Maryland Stem Cell Research Commission.

He was the founding director of the Trent Center for Bioethics, Humanities and History of Medicine at Duke University where he was also a professor of medicine and philosophy. He was appointed as an Academic Icon at the University of Malaya and is a faculty affiliate of the Kennedy Institute of Ethics at Georgetown University.

Dr. Sugarman is currently a member of the Scientific and Research Advisory Board for the Canadian Blood Service and the Ethics and Public Policy Committees of the International Society for Stem Cell Research. He is co-chair of the Johns Hopkins’ Institutional Stem Cell Research Oversight Committee. In addition, he is chair of the Ethics Working Group of the HIV Prevention Trials Network and co-leads the Ethics and Regulatory Core of the NIH Health Care Systems Research Collaboratory.

Dr. Sugarman has been elected as a member of the American Society of Clinical Investigation, Association of American Physicians, and the National Academy of Medicine (formerly the Institute of Medicine). He is a fellow of the American Association for the Advancement of Science, the American College of Physicians and the Hastings Center. He also received a Doctor of Science, honoris causa, from New York Medical College.

Research Interests

  • Informed consent
  • Stem cell research
  • International HIV prevention research
  • HIV cure research
  • Global health
  • Emerging technologies
  • Research oversight
  • Methods in bioethics
  • Pragmatic clinical trials
  • Clinical trial design
  • Umbilical cord blood banking


  • B.S., Duke University
  • M.D., Duke University School of Medicine
  • M.P.H., Johns Hopkins Bloomberg School of Public Health
  • M.A., Applied Ethics, Georgetown University


  • Co-Chair, Institutional Stem Cell Research Oversight Committee, Johns Hopkins University

Recent Publications

  • Collins ME, Rum SA, Sugarman J. Navigating the ethical boundaries of grateful patient fundraising. JAMA. 2018; 320: 975-976.
  • Sugarman J, Barnes M, Rose S, Dumchev K, Sarasvita R, Viet HT, Zeziulin O, Susami H, Go V, Hoffman I, Miller W. Development and implementation of participant safety plans for international research with stigmatized populations. Lancet HIV 2018 Jun 24. doi: 1016/S2352-3018(18)30073-0.
  • Paul A, Merritt MW, Sugarman J. Implementing post-trial access plans for HIV prevention research. J Med Ethics 2018 Feb 27. doi: 10.1136/medethics-2017-104637.[Epub ahead of print]
  • Sugarman J, Anderson J, Baschat AA, Beutler JH, Bienstock JL, Bunchman TE, Desai NM, Gates E, Goldberg A, Grimm PC, Henry LM, Jelin EB, Johnson E, Hertenstein CB, Mastroianni AC, Mercurio MR, Neu A, Nogee LM, Polzin WJ, Ralston SJ, Ramus RM, Singleton MK, Somers MJG, Wang KC, Boss R. Ethical considerations regarding amnioinfusions for treating fetal bilateral renal agenesis. Obstet Gynecol 2017; 131:130-134.
  • Weinfurt KP, Bollinger JM, Brelsford KM, Bresciani M, Lampron Z, Lin L, Topazian RJ, Sugarman J. Comparison of approaches for notification and authorization in pragmatic clinical research evaluating commonly used medical practices. Med Care 2017 Jun 23. doi: 10.1097/MLR.0000000000000762. [Epub ahead of print]
  • Sugarman J, Stolbach A. Ethics and medical toxicology research. J Med Tox 2017 May 24. doi: 10.1007/s13181-017-0618-4. [Epub ahead of print]
  • Munsie M, Hyun I, Sugarman J. Ethical issues in human organoid and gastruloid research. Development 2017 March 15. doi: 10.1242/dev.140111.
  • Sugarman, J, Revill P, Zoulim F, Yazdanpanah Y, Janssen HL, Lim SG, Lewin SR. Ethics and hepatitis B cure research. Gut 2016 Nov 14. doi: 10.1136/gutjnl-2016-313009. [Epub ahead of print]
  • Geller G, Branyon ED, Forbes LK, Topazian RJ, Weir BW, Carrese JA, Beach MC, Sugarman J. ICU-RESPECT: an index to assess patient and family experiences of respect in the intensive care unit. J Crit Care 2016; 36:54-59. doi: 10.1016/J.JC.RC. PMID: 27546748.
  • Carrese JA, Geller G, Branyon ED, Forbes LK, Topazian RJ, Weir BW, Khatib O, Sugarman J. A direct observation checklist to measure respect and dignity in the ICU. Crit Care Med 2016 Sep 22. [Epub ahead of print]
  • Durand CM, Segev D, Sugarman J. Realizing HOPE: The ethics of organ transplantation from HIV-positive donors. Ann Intern Med 2016; 165:138-42.
  • Dawson L, Strathdee SA, London AJ, Lancaster KE, Klitzman R, Hoffman I, Rose S, Sugarman J. Addressing ethical challenges in HIV prevention research with people who inject drugs. J Med Ethics 2016 Apr 25. pii: medethics-2015-102895. doi: 10.1136/medethics-2015-102895. [Epub ahead of print]